Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
New to MyHealth?
Manage Your Care From Anywhere.
Access your health information from any device with MyHealth. ÌýYou can message your clinic, view lab results, schedule an appointment, and pay your bill.
ALREADY HAVE AN ACCESS CODE?
DON'T HAVE AN ACCESS CODE?
NEED MORE DETAILS?
MyHealth for Mobile
WELCOME BACK
or
Ciltacabtagene Autoleucel vs Standard of Care in Patients With Functionally High-Risk Multiple Myeloma: CARTITUDE-4 Subgroup Analysis
À¶Ý®ÊÓƵ
Ciltacabtagene Autoleucel vs Standard of Care in Patients With Functionally High-Risk Multiple Myeloma: CARTITUDE-4 Subgroup Analysis Sidana, S., Weisel, K., Costa, L., van de Donk, N., Cohen, Y., Purtill, D., Touzeau, C., de Larrea, C., Martinez-Lopez, J., Lendvai, N., Slaughter, A., Lonardi, C., Zhao, M., Li, K., Vogel, M., Koneru, M., Patel, N., Florendo, E., Costa Filho, O., Mateos Manteca, M. CIG MEDIA GROUP, LP. 2024: S89View details for